Medical News

RSS

CBIS shares owned by Cannex Therapeutics to be cancelled and re-issued to K&D

Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products announces Federal Court order for CBIS shares owned by Cannex Therapeutics controlled by Steve Kubby to be cancelled and re-issued to K&D. Both K&D and Cannabis Science denounce the "slanderous, malicious attacks" on the Company by its fired CEO Steve Kubby.

15 Jun 2010

BioClinica releases MCC Clinical Trial Performance Metrics reporting solution

BioClinica™, Inc.,, a global provider of clinical trial management services, is the first clinical technology provider to offer a reporting solution that incorporates the industry-standard performance metrics for clinical trials as defined by the Metrics Champion Consortium (MCC).

From Clario 15 Jun 2010

HealthPrize Technologies takes fresh approach to prescription non-adherence problem

HealthPrize Technologies, a web-based software company that motivates people to fill and stay on their prescription medications, announced its official launch today. HealthPrize takes a fresh approach to the problem of medication non-adherence: it tracks users' medication taking and prescription refilling, educates consumers on the importance of taking medication properly, and rewards them for doing so.

15 Jun 2010

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Researchers reported today that Soliris® (eculizumab), a first-in-class terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc., may provide clinical benefits to patients with thrombotic microangiopathy (TMA) resulting from uncontrolled complement activation. TMA, the formation of blood clots in capillaries and small arteries, can lead to life-threatening damage in multiple organs including kidney failure, thrombocytopenia (abnormally low platelet count) and anemia.

15 Jun 2010

CRH Medical's marketing program provides new patient inquiries to physicians

CRH Medical Corporation announced today that its innovative marketing program is providing significant new patient inquiries to physicians listed on the Company's website who have been trained in the use of the Company's proprietary technology and methods known as the CRH O'Regan System.

15 Jun 2010

ActiveCare announces availability of new line of services for aging individuals

ActiveCare Inc. today announced the availability of a new line of services that provide aging individuals and their caregivers many conveniences similar to those offered by in-home care or assisted living, only at the touch of a button and at a fraction of the cost.

15 Jun 2010

Central Washington Hospital improves patient experience with Toshiba' Vantage Titan MR system

In today's demanding health care environment, many community hospitals require imaging equipment that provides a variety of advanced diagnostic exams with features that improve patient cooperation. To offer a variety of high-quality, comfortable MR exams to its patients, Central Washington Hospital in Wenatchee, Wash., selected Toshiba America Medical Systems' Vantage TitanTM MR system.

15 Jun 2010

CombiMatrix Diagnostics receives final licensure documentation and approvals to begin Medicare billing

CombiMatrix Corporation announced today that its laboratory services subsidiary, CombiMatrix Diagnostics, has received the final licensure documentation and approvals from Medicare in order to begin billing for its suite of array-based diagnostics tests.

15 Jun 2010

Adeona's HartLab expands diagnostic testing services to include full array of microbiology testing

Adeona Pharmaceuticals, Inc. announced that its wholly-owned CLIA-certified clinical testing subsidiary, HartLab, has expanded its in-house diagnostic testing services to include a full array of microbiology testing. Adeona believes that that this expansion of services will be accretive to HartLab's revenues in the current quarter and beyond and is consistent with Adeona's plans to continue to build the revenues of its HartLab subsidiary.

15 Jun 2010

EMA COMP grants orphan medicinal product designation for Raptor's DR Cysteamine for cystinosis

Raptor Pharmaceutical Corp., announced that the European Medicines Agency's ("EMA") Committee for Orphan Medicinal Products ("COMP") has issued a positive opinion recommending orphan medicinal product designation for DR Cysteamine for the potential treatment of cystinosis.

15 Jun 2010

Orasi Medical signs agreement to study effect of Lundbeck CNS compounds on human brain

Orasi Medical today announced that it has entered an agreement with H. Lundbeck A/S to study the effect of Lundbeck central nervous system compounds on the human brain.

15 Jun 2010

Inovio commences immunization in U.S. Phase I clinical trial of SynCon H5N1 influenza DNA vaccine

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has immunized its first subject in a U.S. Phase I clinical trial to evaluate its SynCon™ H5N1 (avian) influenza DNA vaccine, VGX-3400X.

15 Jun 2010

UBC announces launch of new office in Lörrach, Germany

United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.

15 Jun 2010

SQNM first-quarter 2010 total revenues up 22%: MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Sequenom Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

15 Jun 2010

Pieris commences PRS-050 anti-VEGF Anticalin Phase I clinical trial for cancer

Pieris AG announced today the initiation of a Phase I clinical trial in cancer patients for its lead program, PRS-050, an anti-VEGF Anticalin. The trial is an open-label, dose-escalating evaluation of the compound's safety and tolerability in patients with solid tumors. Conducted at three sites in Germany, the trial is underway and patients from the first cohort have been dosed.

15 Jun 2010

Cartoon moms combat obesity

Two Latina mothers are heroes in the new comic book, Small Changes Big Results from the Frances Payne Bolton School of Nursing at Case Western Reserve University. Their quest is to create a healthier lifestyle for their children and families and combat obesity.

15 Jun 2010

Project ideas needed from worldwide Alzheimer Disease research community

On the 9 June 2010, 119 participants from industry, academia, and related stakeholder communities in the U.S. and Europe joined Alzforum for a Webinar, "Treating Before Symptoms—ADCS Invites Ideas for Clinical Trials in Very Early AD," presented by Alzheimer's Disease Cooperative Study (ADCS) director Paul Aisen, MD.

15 Jun 2010

Best gift for Father's Day: CISRC

While Father's Day gifts range from the touching to the hilarious, the best gift you might give your father or spouse is help and support during the difficult time of a cancer diagnosis.

15 Jun 2010

Tips for correct application of sunscreen

You've gotten the message about the importance of sun protection, you're stocked up on sunscreen that's at least 15 SPF, and you're diligent about putting it on before you head outside. Once you've gotten this far, there's no reason to risk sunburns by applying it incorrectly. But, all too often, that's exactly what happens, says a Saint Louis University dermatologist.

15 Jun 2010

Researchers study how APOE4 becomes a potent risk factor for Alzheimer's disease

A molecule implicated in Alzheimer's disease interferes with brain cells by making them unable to "recycle" the surface receptors that respond to incoming signals, researchers at UT Southwestern Medical Center have found.

15 Jun 2010

Medical News

CBIS shares owned by Cannex Therapeutics to be cancelled and re-issued to K&D

BioClinica releases MCC Clinical Trial Performance Metrics reporting solution

HealthPrize Technologies takes fresh approach to prescription non-adherence problem

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

CRH Medical's marketing program provides new patient inquiries to physicians

ActiveCare announces availability of new line of services for aging individuals

Central Washington Hospital improves patient experience with Toshiba' Vantage Titan MR system

CombiMatrix Diagnostics receives final licensure documentation and approvals to begin Medicare billing

Adeona's HartLab expands diagnostic testing services to include full array of microbiology testing

EMA COMP grants orphan medicinal product designation for Raptor's DR Cysteamine for cystinosis

Orasi Medical signs agreement to study effect of Lundbeck CNS compounds on human brain

Inovio commences immunization in U.S. Phase I clinical trial of SynCon H5N1 influenza DNA vaccine

UBC announces launch of new office in Lörrach, Germany

SQNM first-quarter 2010 total revenues up 22%: MicroStockProfit.com

Pieris commences PRS-050 anti-VEGF Anticalin Phase I clinical trial for cancer

Cartoon moms combat obesity

Project ideas needed from worldwide Alzheimer Disease research community

Best gift for Father's Day: CISRC

Tips for correct application of sunscreen

Researchers study how APOE4 becomes a potent risk factor for Alzheimer's disease

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News